サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1564044

乳房病変の局在の世界市場

Breast Lesion Localization

出版日
ページ情報
英文 193 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
乳房病変の局在の世界市場
出版日: 2024年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

乳房病変の局在の世界市場は2030年までに4億3,020万米ドルに達する見込み

2023年に3億1,580万米ドルと推定される乳房病変の局在の世界市場は、2030年には4億3,020万米ドルに達し、分析期間2023～2030年のCAGRは4.5%で成長すると予測されます。本レポートで分析したセグメントの1つである乳房生検は、CAGR 5.0％を記録し、分析期間終了時には3億920万米ドルに達すると予測されます。ランペクトミー分野の成長率は、分析期間中CAGR 3.3％と推定されます。

米国市場は8,580万米ドルと推定、中国はCAGR4.2％で成長予測

米国の乳房病変の局在市場は2023年に8,580万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGRを4.2%として、2030年までに6,780万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.3％と3.7％と予測されています。欧州では、ドイツがCAGR約4.5%で成長すると予測されています。

世界の乳房病変の局在市場- 主要動向と促進要因のまとめ

現代医療において乳房病変の局在が重要な理由とは？

乳房病変の局在は、乳がんの管理、特に早期発見と治療計画に欠かせないステップです。しかし、この手順にはどのようなものがあるのでしょうか？基本的には、生検や手術の際に外科医を誘導するために、乳房組織内の疑わしい部分に印をつけることです。乳がんの罹患率が世界的に上昇するにつれ、正確な局在診断法の重要性は増すばかりです。病変部にワイヤーを挿入してマーキングするワイヤーローカライゼーションなどの伝統的な方法は、数十年にわたって使用されてきましたが、より高度な技術に取って代わられつつあります。これらの新しいアプローチは、より精度が高く、不快感が少なく、小さい病変や触知できない病変をより効果的に標的にすることができ、患者の転帰を大きく向上させる。超音波、マンモグラフィ、磁気共鳴画像法（MRI）のような進化した技術がこれらの手技の指針となることで、医療界は標的を絞った介入を行うための設備がこれまで以上に整い、周辺組織へのダメージを最小限に抑え、回復率を向上させています。

乳房病変の局在技術の進歩とは？

近年、乳房病変の局在テクノロジーは大きな進化を遂げています。歴史的には、ワイヤーガイド下定位（WGL）がゴールドスタンダードでした。しかし、レーダー・ローカライゼーション、RFID（Radiofrequency Identification）、磁気シードなど、ワイヤーを使用しないローカライゼーションが登場し、より合理的で効率的な手順を提供するようになりました。例えば、レーダー照射はレーダー波を用いて病巣を正確に狙い撃ちするもので、ワイヤーに伴う不快感や制約がないです。RFIDタグは、病巣に小さなタグを埋め込むもので、長期間の留置が可能なため、より柔軟なスケジューリングが可能となります。もう一つの革新的な方法である磁気シードローカリゼーションは、病巣に小さな磁気シードを挿入するもので、手術中に簡単に検出することができます。これらの技術は、触知不能な病変を持つ患者にとって特に有益であり、誤触知による再手術の必要性を減らし、患者の経験と医師の精度の両方を向上させる。低侵襲で高精度の技術へのシフトは、精度と患者の快適さが最優先される個別化医療のより広範な動向を強調するものです。

ガイドラインや患者ニーズの変化は、乳房病変の局在をどのように形成しているのでしょうか？

乳房病変の局在の臨床状況は、医療ガイドラインの更新や患者の期待の変化など、いくつかの重要な動向によって形成されています。American Society of Breast Surgeons（ASBrS）などの団体のガイドラインは、最小限の断端で局所を切除する必要性を強調しており、これは局所の切除方法の選択に直接影響しています。外科医は、リアルタイムのフィードバックを提供し、精度を高め、悪性組織の切除に高い信頼性を確保する技術をますます求めるようになっています。患者が不安や不快感を軽減する低侵襲な治療法を求めるようになり、患者中心の治療も決定的な要因として浮上してきました。より柔軟なスケジューリングと、診断から手術までの時間短縮への要求は、ワイヤの安定性を確保するためにタイミングが重要であった従来のワイヤガイド下定位による制約をなくす技術の採用に拍車をかけた。その結果、手術の数日前に埋め込むことができる非ワイヤー定位法は、患者とヘルスケアプロバイダーの双方に利便性と安心感をもたらしています。

乳房病変の局在市場の主な成長促進要因は？

乳房病変の局在市場の成長は、より先進的で患者に優しい技術に対する需要の高まりを反映した、いくつかの要因によって牽引されています。第一に、RFID、磁気シード、レーダーなどの非配線式ローカライゼーション法の技術進歩により、精度と患者の快適性の両方が向上し、ヘルスケア施設がこれらの技術革新を採用するようになった。第2に、世界の乳がん罹患率の上昇により、早期発見・治療戦略の一環として正確な位置決め技術の必要性が高まっています。第三に、進化するヘルスケア政策とバリュー・ベース・ケアへの注目の高まりが、合併症の少ない、より良い結果をもたらす技術への投資を病院に促し、現代の医療報酬モデルに合致しています。さらに、新興諸国における高齢化と乳がん検診率の向上は、市場開拓の新たな機会を生み出しています。最後に、低侵襲手術に対する患者の嗜好と、より柔軟なスケジューリングを可能にする技術が、ワイヤーガイド法からのシフトを加速し、革新的な乳房病変の局在ソリューションの需要をさらに押し上げています。これらの要因が相まって、乳房病変の局在の状況は一変し、技術的進歩、患者体験、臨床転帰の改善を優先する市場が形成されつつあります。

調査対象企業の例（全43件）

  • Argon Medical Devices, Inc.
  • BARD, A Becton, Dickinson Company
  • Cianna Medical, Inc.
  • Cook Medical LLC
  • CP Medical Corporation
  • Somatex Medical Technologies GmbH
  • Sterylab Srl

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP10796

Global Breast Lesion Localization Market to Reach US$430.2 Million by 2030

The global market for Breast Lesion Localization estimated at US$315.8 Million in the year 2023, is expected to reach US$430.2 Million by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Breast Biopsy, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$309.2 Million by the end of the analysis period. Growth in the Lumpectomy segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$85.8 Million While China is Forecast to Grow at 4.2% CAGR

The Breast Lesion Localization market in the U.S. is estimated at US$85.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$67.8 Million by the year 2030 trailing a CAGR of 4.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Breast Lesion Localization Market - Key Trends and Drivers Summarized

Why Is Breast Lesion Localization Critical in Modern Medicine?

Breast lesion localization is a vital step in the management of breast cancer, especially for early detection and treatment planning. But what does this procedure entail? Essentially, it involves marking suspicious areas within the breast tissue to guide surgeons during biopsy or surgery. As breast cancer rates rise globally, the importance of accurate localization methods has only increased. Traditional methods such as wire localization, where a wire is inserted to mark the lesion, have been used for decades but are being phased out in favor of more advanced techniques. These new approaches offer higher precision, less discomfort, and more effective targeting of smaller or non-palpable lesions, greatly enhancing patient outcomes. With evolving technologies like ultrasound, mammography, and magnetic resonance imaging (MRI) guiding these procedures, the medical community is better equipped than ever to perform targeted interventions, minimizing damage to surrounding tissues and improving recovery rates.

What Are The Advancements in Breast Lesion Localization Technology?

In recent years, breast lesion localization technologies have undergone significant evolution. Historically, wire-guided localization (WGL) was the gold standard. However, non-wire alternatives like radar localization, radiofrequency identification (RFID), and magnetic seeds have emerged, offering more streamlined and efficient procedures. For instance, radar localization uses radar waves to precisely target lesions without the discomfort or limitations associated with wires. RFID tags, which involve implanting a small tag into the lesion, allow for more flexible scheduling as they can remain in place for longer periods. Magnetic seed localization, another innovative method, involves inserting a small magnetic seed into the lesion, which can then be easily detected during surgery. These technologies are especially beneficial for patients with non-palpable lesions, reducing the need for repeated surgeries due to mislocalization and enhancing both the patient's experience and the physician’s accuracy. The shift toward minimally invasive, highly accurate techniques underscores a broader trend in personalized medicine, where precision and patient comfort are paramount.

How Are Changing Guidelines and Patient Needs Shaping Breast Lesion Localization?

The clinical landscape for breast lesion localization has been shaped by several key trends, including updated medical guidelines and changing patient expectations. Guidelines from organizations like the American Society of Breast Surgeons (ASBrS) emphasize the need for localized excision with minimal margins, which directly impacts the choice of localization methods. Surgeons are increasingly seeking techniques that provide real-time feedback, enhance accuracy, and ensure a high degree of confidence in the excision of malignant tissue. Patient-centric care has also emerged as a defining factor, as patients seek minimally invasive options that reduce anxiety and procedural discomfort. The demand for more flexible scheduling and reduced time between diagnosis and surgery has spurred the adoption of technologies that eliminate the constraints imposed by traditional wire-guided localization, where timing was critical to ensure wire stability. As a result, non-wire localization methods, which can be implanted days before surgery, provide more convenience and peace of mind for both patients and healthcare providers.

What Are The Key Growth Drivers In The Breast Lesion Localization Market?

The growth in the breast lesion localization market is driven by several factors, reflecting the increasing demand for more advanced, patient-friendly technologies. First, technological advancements in non-wire localization methods, such as RFID, magnetic seeds, and radar, have improved both accuracy and patient comfort, pushing healthcare facilities to adopt these innovations. Second, the rising incidence of breast cancer globally has led to a greater need for precise localization techniques as part of early detection and treatment strategies. Third, evolving healthcare policies and the increasing focus on value-based care have encouraged hospitals to invest in technologies that offer better outcomes with fewer complications, aligning with modern medical reimbursement models. Additionally, the aging population and increased breast cancer screening rates in developing countries are creating new opportunities for market expansion. Lastly, patient preferences for minimally invasive procedures and technologies that allow for more flexible scheduling have accelerated the shift away from wire-guided methods, further driving the demand for innovative breast lesion localization solutions. Together, these factors are transforming the landscape of breast lesion localization, fostering a market that prioritizes technological advancements, patient experience, and improved clinical outcomes.

Select Competitors (Total 43 Featured) -

  • Argon Medical Devices, Inc.
  • BARD, A Becton, Dickinson Company
  • Cianna Medical, Inc.
  • Cook Medical LLC
  • CP Medical Corporation
  • Somatex Medical Technologies GmbH
  • Sterylab Srl

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Breast Lesion Localization - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Breast Cancer Globally Drives Demand for Accurate and Efficient Localization Technologies
    • Advancements in Non-Wire Localization Techniques Propel Growth in Breast Lesion Localization Market
    • Increased Adoption of Radiofrequency Identification (RFID) and Magnetic Seed Localization Expands Addressable Market Opportunities
    • Adoption of Image-Guided Localization Techniques Accelerates Market Growth
    • Growing Focus on Reducing Re-Excision Rates and Improving Surgical Outcomes Propels Demand for Advanced Localization Tools
    • Surge in Demand for Targeted Breast Surgeries and Personalized Treatment Plans Drives Adoption of Localization Technologies
    • Here's How Advances in Magnetic Seed and Radar Localization Techniques are Creating New Market Opportunities
    • Increased Awareness of Breast Cancer Screening Programs Globally Generates New Opportunities for Localization Technologies
    • Rising Adoption of RFID Localization in Complex Breast Surgeries Spurs Technological Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Breast Lesion Localization Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Breast Lesion Localization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Breast Lesion Localization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Breast Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Breast Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Lumpectomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Lumpectomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Wire Localization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Wire Localization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Magnetic Localization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Magnetic Localization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Radioisotope Localization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Radioisotope Localization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Method Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Other Method Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 16: USA Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 17: USA 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 18: USA Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 19: USA 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: Canada 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • JAPAN
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 24: Japan Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Japan 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Japan 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • CHINA
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 28: China Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: China 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 30: China Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: China 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • EUROPE
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Breast Lesion Localization by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe 7-Year Perspective for Breast Lesion Localization by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Europe 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Europe 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • FRANCE
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: France 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 40: France Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: France 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • GERMANY
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 42: Germany Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Germany 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Germany 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • ITALY
    • TABLE 46: Italy Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Italy 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 48: Italy Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Italy 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • UNITED KINGDOM
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 50: UK Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: UK 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 52: UK Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: UK 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 54: Rest of Europe Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: Rest of Europe 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Rest of Europe 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Breast Lesion Localization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 58: Asia-Pacific Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Asia-Pacific 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Asia-Pacific 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 62: Rest of World Recent Past, Current & Future Analysis for Breast Lesion Localization by Usage - Breast Biopsy and Lumpectomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Rest of World 7-Year Perspective for Breast Lesion Localization by Usage - Percentage Breakdown of Value Sales for Breast Biopsy and Lumpectomy for the Years 2024 & 2030
    • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Breast Lesion Localization by Method Type - Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Rest of World 7-Year Perspective for Breast Lesion Localization by Method Type - Percentage Breakdown of Value Sales for Wire Localization, Magnetic Localization, Radioisotope Localization and Other Method Types for the Years 2024 & 2030

IV. COMPETITION